Latest news
David Kirn Sells 12,415 Shares of 4D Molecular Therapeutics (NASDAQ:FDMT) Stock - MarketBeatMarketBeat · Tue, 04 Aug 2026 21:31:25 GMT4D Molecular Therapeutics (FDMT) CEO sells 12,415 shares via 10b5-1 plan - Stock TitanStock Titan · Tue, 04 Aug 2026 20:46:01 GMT4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987 - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMTONYX-015 Appears Promising in Advanced Head and Neck Cancer - CancerNetworkCancerNetwork · Fri, 31 Jul 2026 17:00:00 GMT